Artemis Therapeutics, Inc. (ATMS)

OTCMKTS: ATMS · Delayed Price · USD
0.950 0.000 (0.00%)
Jan 10, 2022 4:00 PM EST - Market closed
Market Cap4.90M
Revenue (ttm)n/a
Net Income (ttm)-118,879
Shares Out5.15M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,005
Open0.950
Previous Close0.950
Day's Range0.950 - 0.950
52-Week Range0.150 - 7.020
Beta-0.34
Analystsn/a
Price Targetn/a
Earnings Daten/a

About ATMS

Artemis Therapeutics Inc. does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.

IndustryPharmaceuticals
Employees1
Stock ExchangeOTCMKTS
Ticker SymbolATMS
Full Company Profile

News

There is no news available yet.